Skip to Main Content

News Center

Research

SOP Researchers Make Progress Toward Antiviral Treatments for COVID-19

September 16, 2020

Information about the molecular shape of the viruses that cause COVID-19, SARS, and MERS reveals structural similarities that suggest possible drug treatments.

CERSI Conference Spotlights Latest Advances in Topical Drug Development

August 24, 2020

Virtual event brings together more than 500 attendees, including stakeholders from the FDA, academia, and industry.

PATIENTS Conference Showcases National Efforts to Build Capacity for Patient-Centered Research

August 7, 2020

Presentations from academic institutions and health care systems across the United States shared best practices and strategies to support the continued advancement of patient-centered outcomes research.

SOP’s Yu Leads Research to Assure Vaccine Quality at Point-of-Care

June 10, 2020

New non-invasive quality assurance method developed by Dr. Bruce Yu and his team offers more effective way to detect freezing events in vaccines at the point-of-care.

Eddington Names New Department Chair for Pharmaceutical Sciences

March 25, 2020

Peter Swaan, PhD, succeeds Paul Shapiro, PhD, as chair of the Department of Pharmaceutical Sciences at the University of Maryland School of Pharmacy.

SOP’s Onukwugha Appointed to Statewide Prescription Drug Affordability Board

February 24, 2020

Independent group will evaluate costs for certain new and existing medications and make recommendations about how to curb high drug prices.

Study Suggests Restrictive Housing Vouchers Improve Recipients’ Health, Life Expectancy

January 31, 2020

Study co-authored by Dr. Zafar Zafari finds housing vouchers restricted to use in low-poverty neighborhoods cost less than traditional vouchers and help improve recipients’ health and life expectancy.